ALBERTDAVDBSEAlbert David Ltd-$HighNeutral
Announced Tue, 12 May · 20:15 IST

Book closure date

Ceo ResignedCeo Appointed ExternalManagement Changes View source PDF

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-10.5%1-day move
₹790.00
prior close
₹730.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-1.9-2.3-2.1-10.5-8.6-10.1-9.2-10.4-10.6-8.8-8.3-11.2
Up moveDown movePending
AI summary

Albert David Limited announced appointment of Mr. Amit Mahla as CEO effective May 12, 2026, filling a vacancy left by Mr. Umesh Manohar Kunte who resigned as Managing Director & CEO on December 18, 2025 (approximately 5 months prior). The company reported audited FY2026 results showing revenue of Rs 33,359.81 lakhs but a net loss of Rs 149.47 lakhs, a sharp decline from FY2025 profit of Rs 1,720.08 lakhs. The board recommended a final dividend of Rs 5 per share (50%) for FY2026, subject to shareholder approval at the 87th AGM on August 6, 2026. Record date for dividend is July 30, 2026.

Likely market impact

The company saw a significant turnaround from profit to loss in FY2026. The new CEO appointment after a 5-month vacancy brings experienced pharmaceutical leadership, which could be positive for strategic direction. However, the financial performance deterioration may concern investors in the near term despite the dividend announcement.